Retrievable Stents Market Size, Share, Growth, Forecast and Outlook (2024-2031)

Global Retrievable Stents Market  is segmented By Type (Partially Recoverable, Completely Recoverable) By Indication (Acute intracranial atherosclerotic Stenosis, Intracranial Vascular Disease, Cerebral Aneurysms, Intracranial Aneurysms, Acute Stroke, Others) By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Retrievable Stents Market  Overview

Global Retrievable Stents market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

With the innovative retrievable stent, a blood clot is trapped inside the body until it is removed by passing the stent through an artery, into the brain, and out of the body. Cardiologists use a similar procedure when they open up arteries following a heart attack.

One notable distinction between them and conventional stents is their removable nature. In individuals who have a history of blood clots or frail blood arteries, they provide an excellent alternative because of their increased risk of complications from permanent stents.

Retrievable Stents Market  Scope

For more details on this report – Request for Sample

Retrievable Stents Market  Dynamics: Drivers & Restraints

Increasing incidence of cardiovascular diseases

The increasing number of cardiovascular diseases is expected to drive the market growth.  The increasing patient pool with cardiovascular diseases will increase the demand for retrievable stents. This includes an increase in the need for stents, which are small mesh tubes that open clogged or restricted arteries to relieve pain and restore blood flow.

For instance, according to the report by the CDC in 2021, in the US, there are over 795,000 stroke victims annually. Of them, about 610,000 are new or first-time strokes. Approximately 185,000 stroke victims—roughly 1 in 4—have had a prior stroke. Ischemic strokes, in which blood flow to the brain is obstructed, account for about 87% of all stroke cases. Thus, an increase in the incidence of cardiovascular diseases is expected to drive the market growth.

High procedural costs  

Because of their complicated design and retrieval procedures, retrievable stents might cost more than regular stents. Patients, especially those without sufficient insurance coverage, may be reluctant to select this choice due to the increased expense burden. Thus, high costs are expected to hinder the market growth.

Retrievable Stents Market  Segment Analysis

The global retrievable stents market is segmented based on type, indication, end-user and region.

The cerebral aneurysm segment is expected to dominate the market growth

Cerebral aneurysm segment is expected to hold a dominant position in the market growth. A cerebral aneurysm is a critical condition that has to be treated as it blocks the blood vessels. An increase in the cerebral aneurysm will increase the demand for treating the condition.

For instance, according to the Brain Aneurysm Foundation, it is estimated that about 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes.

Brain aneurysms are most prevalent in people ages 35 to 60, but can occur in children as well. Most aneurysms develop after the age of 40. Women are more likely than men to have a brain aneurysm and mainly those over the age of 55, have a higher risk of brain aneurysm rupture than men. Thus, the above factors are driving the segment growth. 

Retrievable Stents Market  Geographical Analysis

North America is expected to hold a significant position in the retrievable stents market share

North America is expected to hold the dominant position in the market share due to the increasing incidence of cardiovascular diseases, the presence of the major companies in the region and also the strategies followed by the major companies in the region. Additionally, an increase in the number of medical device companies in the region is also expected to hold the region in the dominant market share. 

For instance, in January 2024, Reflow Medical, Inc. received CE Mark certification in the European Union for the Bare Temporary Spur Stent System. The device is intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption. 

Retrievable Stents Market  COVID-19 Impact Analysis

COVID-19 has impacted the market growth significantly. The manufacturing companies have been shut down due to the imposition of lockdown and due to the lack of workers during that period. The supply chain has been disrupted due to the lockdown and the restrictions that are being imposed at the borders between the countries.

Retrievable Stents Market  Competitive Landscape

The major global players in the market include NeuroSafe Medical Co., Ltd., Stron Medical, Boston Scientific Corporation, Allium Medical, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Translumina Therapeutics, and Lepu Medical among others.

Why Purchase the Report?

• To visualize the global retrievable stents market segmentation based on type, indication, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of retrievable stents market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global retrievable stents market report would provide approximately 53 tables, 49 figures and 182 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies